Part 1: Clinical Trials

1 trial of Part 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Part 1: new trials by email Literature Review of Part 1 trials Research Report on Part 1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
Part 1, Part 2 - Mild to Moderate COVID-19
Phase 2 / Phase 3TerminatedDaewoong Pharmaceutical Co. LTD.4322020-09-112022-06-15

Sponsors

Daewoong Pharmaceutical Co. LTD. (1)

Countries

South Korea (1)

Results publications

PMID 36515544